Seres Therapeutics (MCRB)
(Delayed Data from NSDQ)
$0.74 USD
+0.01 (1.81%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $0.74 0.00 (-0.36%) 6:24 PM ET
3-Hold of 5 3
F Value C Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $-0.36 | 0.00% |
Earnings Summary
For their last quarter, Seres Therapeutics (MCRB) reported earnings of -$0.32 per share, beating the Zacks Consensus Estimate of $-0.40 per share. This reflects a positive earnings surprise of 20.00%. Look out for MCRB's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of -$0.36 per share, reflecting a year-over-year increase of 36.84%.
Earnings History
Price & Consensus
Zacks News for MCRB
Seres Therapeutics (MCRB) Misses Q2 Earnings Estimates
MCRB: What are Zacks experts saying now?
Zacks Private Portfolio Services